Israeli college to offer degree specializing in medical cannabis

‘The cannabis industry today is what the cyber industry was 10 years ago – Israel needs and can lead this industry, too' – college president Prof. Itzhak Harpaz.

By
July 8, 2019 19:19
2 minute read.
Employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in nort

Employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel. (photo credit: AMIR COHEN/REUTERS)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

An academic college in the North will become the first in the country to offer an undergraduate degree with a specialization in medical cannabis.

The Max Stern Yezreel Valley College, home to approximately 5,000 students and located between Afula and Nazareth, announced on Monday that new students will be able to pursue a B.A. in Behavioral Sciences with a specialization in medical cannabis, enabling graduates to play a role in one of Israel’s “most prosperous industries.”

Courses offered in the program that will commence during the next academic year will focus on the growth and production of medical cannabis, medicine, pharmacology, economics and law.

“The goal of the program is to train graduates in new professions in the field of medical cannabis, while academizing the field,” said Dr. Efrat Barel, head of the new program. “The extensive educational base will enable graduates to understand all required aspects, and their integration into the workforce will bring added value to the sector.”

In the third year of studies, students will also be provided with hands-on experience in cannabis farms and production plants, and attend seminars hosted by the research divisions of medical cannabis pharma companies and university research laboratories.

“The cannabis industry today is what the cyber industry was 10 years ago,” said Yezreel Valley College President Prof. Itzhak Harpaz. “Israel needs and can lead this industry, too. This industry is already characterized by many new ventures and technologies, and it is already clear that its economic potential can reach tens of billions of dollars. We are proud to be the first to develop an academic specialization in the field of medical cannabis.”

In January, the government approved exports of Israeli-grown medical cannabis to the worldwide legal market, estimated to be worth $28 billion by 2024. It estimated that the state could earn between NIS 1 billion and NIS 4 billion ($1.09b.) per year from exports. Licenses will be exclusively granted by the Health Ministry, and will require police approval.

“Considering the significant impact that this industry will have on the Israeli economy in the coming years, skilled professionals are required to enter the field of medical cannabis and progress alongside it,” Harpaz said.

Steps to facilitate exports have been followed by domestic reforms announced by the Health Ministry in recent months, including enabling patients with certain medical conditions to receive medical cannabis by prescription rather than requiring Health Ministry permission, as well as plans to establish an inter-ministerial committee to supervise the pricing of cannabis products.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

July 23, 2019
Blue and White begins campaign for Ethiopian vote

By JEREMY SHARON

Cookie Settings